Rituximab: Difference between revisions
From OncoWiki
Jump to navigationJump to search
m (→Indications) |
m (1 revision) |
(No difference)
|
Latest revision as of 02:18, 7 February 2012
Drug information
Prescribing information (Genentech)
Indications
Indolent NHL
- 375 mg/m2 iv qw x 4 followed by 375 mg/m2 iv q2m x 4
- 375 mg/m2 iv qw x 4 followed by 375 mg/m2 iv qw x 4 every 6 months
Chronic Lymphocytic Leukemia
- 375 mg/m2 iv qw x 4 wks q6m x 4 courses